KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Net Cash Flow: 2017-2025

Historic Net Cash Flow for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to -$45.4 million.

  • Guardant Health's Net Cash Flow rose 86.97% to -$45.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 99.28%. This contributed to the annual value of -$502.2 million for FY2024, which is 150.59% down from last year.
  • According to the latest figures from Q3 2025, Guardant Health's Net Cash Flow is -$45.4 million, which was up 34.45% from -$69.3 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Net Cash Flow registered a high of $675.3 million during Q4 2023, and its lowest value of -$356.9 million during Q2 2022.
  • For the 3-year period, Guardant Health's Net Cash Flow averaged around $49.9 million, with its median value being -$3.3 million (2024).
  • As far as peak fluctuations go, Guardant Health's Net Cash Flow crashed by 614.42% in 2022, and later soared by 5,365.04% in 2025.
  • Quarterly analysis of 5 years shows Guardant Health's Net Cash Flow stood at -$339.9 million in 2021, then surged by 94.76% to -$17.8 million in 2022, then spiked by 3,892.93% to $675.3 million in 2023, then slumped by 108.43% to -$56.9 million in 2024, then soared by 86.97% to -$45.4 million in 2025.
  • Its Net Cash Flow stands at -$45.4 million for Q3 2025, versus -$69.3 million for Q2 2025 and $173.3 million for Q1 2025.